Elsewhere reviews. Interferon signalling through arachidonic acid‐dependent pathways: A clue to adjuvant therapy for chronic viral hepatitis?

Hepatology

Volumn 14, Issue 2, 1991, Pages 392-394

  Baskin, Gordon ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; INTERFERON; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ARTICLE; CHRONIC DISEASE; DRUG RESISTANCE; HUMAN; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIRUS HEPATITIS;

ADJUVANTS, PHARMACEUTIC; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CHRONIC DISEASE; DRUG RESISTANCE; HEPATITIS, VIRAL, HUMAN; HUMAN; INTERFERONS; SIGNAL TRANSDUCTION;

EID: 0026209377     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840140229     Document Type: Article

References (14)

1. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial
2. Randomized, controlled trial of recombinant human α‐interferon in patients with chronic hepatitis B
3. A randomized, controlled trial of interferon alfa‐2b, alone and following prednisone withdrawal, in the treatment of chronic hepatitis B
4. Twelve months recombinant interferon alfa treatment in chronic non‐A non‐B hepatitis [Abstract]
5. Pilot study of recombinant human α‐interferon for chronic type B hepatitis
6. Long‐term follow‐up in a randomized controlled trial of recombinant α2‐interferon in Chinese patients with chronic hepatitis B infection
7. Interferon production by peripheral lymphocytes in HBsAg‐positive liver disease
8. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life
9. Interferon‐γ production by peripheral blood mononuclear cells of patients with chronic liver disease
10. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B infection
11. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon
12. Interferon antibodies may negate the antiviral effects of recombinant α‐interferon treatment in patients with chronic hepatitis B infection
13. Changes in immune function and lymphocyte subsets in patients with chronic non‐A non‐B hepatitis treated with recombinant human α‐interferon [Abstract]
14. Signal transduction by interferon‐α through arachidonic acid metabolism